Last 46 quarters of trend data · Healthcare · Medical - Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
Penumbra, Inc.'s quarterly P/E stands at 100.1x, up 49.8% year-over-year — indicating the stock has re-rated higher or earnings have softened. EV/EBITDA has expanded 49.0% YoY to 84.7x, reflecting rising market expectations or slowing EBITDA growth.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 70.18 | 100.11 | 64.77 | 54.13 | 55.79 | 66.85 | 69.03 | 64.77 | — | 199.27 | 45.57 | 262.95 | 179.20 |
| — | +49.8% | -6.2% | -16.4% | — | -66.5% | +51.5% | -75.4% | — | -37.1% | -91.8% | — | — | |
| P/S Ratio | 8.89 | 8.66 | 7.95 | 7.02 | 7.42 | 8.08 | 7.39 | 6.32 | 5.83 | 7.89 | 8.68 | 8.75 | 12.89 |
| — | +7.2% | +7.5% | +11.0% | +27.2% | +2.4% | -14.9% | -27.8% | -54.8% | -30.1% | -11.2% | +4.1% | +128.5% | |
| P/B Ratio | 8.73 | 8.81 | 8.58 | 7.33 | 7.78 | 8.63 | 8.10 | 6.89 | 6.01 | 7.30 | 8.38 | 8.59 | 12.65 |
| — | +2.0% | +5.9% | +6.3% | +29.5% | +18.2% | -3.3% | -19.8% | -52.5% | -31.3% | -3.2% | +16.4% | +160.8% | |
| P/FCF | 71.32 | 44.29 | 44.99 | 59.24 | 85.74 | 73.74 | 50.97 | 37.31 | 96.56 | 67.68 | 75.75 | 86.21 | 264.32 |
| — | -39.9% | -11.7% | +58.8% | -11.2% | +9.0% | -32.7% | -56.7% | -63.5% | -77.0% | — | — | — | |
| EV / EBITDA | 60.51 | 84.74 | 48.20 | 47.99 | 53.26 | 56.86 | 48.90 | 47.83 | — | 112.12 | 59.13 | 122.91 | 138.26 |
| — | +49.0% | -1.4% | +0.3% | — | -49.3% | -17.3% | -61.1% | — | -40.7% | -69.8% | -22.0% | -34.2% | |
| EV / EBIT | 66.10 | 84.74 | 48.25 | 46.77 | 54.08 | 58.38 | 51.62 | 47.11 | — | 181.78 | 100.91 | 77.95 | 170.23 |
| — | +45.1% | -6.5% | -0.7% | — | -67.9% | -48.8% | -39.6% | — | -47.2% | -77.9% | -77.0% | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Penumbra, Inc.'s operating margin was 10.2% in Q1 2026, down 5.2 pp QoQ and down 2.2 pp YoY. The trailing four-quarter average of 12.8% exceeds the current quarter, suggesting the latest result may reflect seasonal weakness or a one-off headwind.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 67.1% | 67.6% | 68.0% | 67.8% | 66.0% | 66.6% | 66.8% | 66.5% | 54.4% | 65.0% | 65.7% | 65.6% | 63.8% |
| — | +1.5% | +1.8% | +1.9% | +21.3% | +2.5% | +1.7% | +1.4% | -14.8% | +3.9% | +5.0% | +3.6% | -0.8% | |
| Operating Margin | 13.5% | 10.2% | 15.4% | 13.8% | 12.0% | 12.4% | 13.6% | 11.7% | -27.0% | 4.3% | 12.3% | 4.7% | 6.8% |
| — | -18.0% | +13.4% | +17.2% | +144.5% | +186.7% | +10.2% | +152.1% | -495.3% | +30.9% | +463.2% | +83.2% | +10356.2% | |
| Net Margin | 12.7% | 8.7% | 12.3% | 12.9% | 13.3% | 12.1% | 10.7% | 9.8% | -20.1% | 3.9% | 19.0% | 3.4% | 7.3% |
| — | -28.1% | +15.1% | +31.8% | +166.3% | +206.5% | -43.9% | +188.4% | -377.3% | +11.3% | +986.7% | +420.0% | +509.7% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 13.8% | 2.2% | 3.4% | 3.5% | 3.6% | 3.3% | 3.0% | 2.6% | -5.1% | 0.9% | 4.7% | 0.8% | 1.8% |
| — | -32.3% | +13.8% | +32.6% | +170.9% | +259.3% | -37.1% | +207.0% | -380.7% | +9.1% | +1108.2% | +463.3% | +574.5% | |
| ROA | 10.6% | 1.7% | 2.7% | 2.7% | 2.8% | 2.5% | 2.2% | 2.0% | -3.9% | 0.7% | 3.6% | 0.6% | 1.3% |
| — | -30.3% | +18.6% | +36.9% | +171.7% | +257.6% | -37.6% | +208.5% | -388.3% | +13.3% | +1144.8% | +470.6% | +578.2% | |
| ROIC | 11.3% | 2.0% | 3.3% | 3.1% | 2.8% | 2.9% | 3.1% | 2.5% | -5.2% | 0.7% | 2.1% | 0.8% | 1.1% |
| — | -31.4% | +7.1% | +26.6% | +154.3% | +288.8% | +44.1% | +214.4% | -559.1% | +43.1% | +573.1% | +118.1% | +12393.5% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Penumbra, Inc.'s Debt/EBITDA ratio is 5.7x, up from 3.4x last quarter — elevated, raising questions about debt serviceability. Debt/Equity has declined for 7 consecutive quarters, reflecting a deleveraging trend.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.15 | 0.15 | 0.15 | 0.16 | 0.17 | 0.18 | 0.19 | 0.21 | 0.20 | 0.19 | 0.20 | 0.21 | 0.22 |
| — | -19.4% | -20.7% | -22.2% | -13.5% | -5.4% | -2.4% | -0.9% | -9.1% | -15.6% | -15.8% | -7.2% | -4.4% | |
| Debt / EBITDA | 1.06 | 5.65 | 3.45 | 4.23 | 4.76 | 4.86 | 4.74 | 5.74 | — | 11.80 | 5.57 | 11.70 | 9.40 |
| — | +16.2% | -27.2% | -26.3% | — | -58.8% | -15.0% | -51.0% | — | -26.3% | -73.4% | -37.3% | -75.2% | |
| Current Ratio | 6.64 | 6.02 | 6.64 | 6.73 | 6.75 | 6.30 | 6.01 | 5.82 | 6.25 | 6.12 | 6.06 | 5.99 | 5.74 |
| — | -4.4% | +10.6% | +15.6% | +8.1% | +3.0% | -0.8% | -2.8% | +8.8% | +13.8% | +16.2% | +14.4% | +16.5% | |
| Quick Ratio | 4.29 | 3.95 | 4.29 | 4.18 | 4.04 | 3.68 | 3.44 | 3.25 | 3.77 | 3.51 | 3.49 | 3.41 | 3.25 |
| — | +7.4% | +24.7% | +28.5% | +7.1% | +4.8% | -1.5% | -4.5% | +16.0% | +16.2% | +19.9% | +16.8% | +12.3% | |
| Interest Coverage | — | — | — | 155.81 | 143.04 | 137.20 | 132.57 | 119.39 | -225.38 | 30.18 | — | — | 45.00 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 46 years · Updated daily
Deep dive into PEN consensus models and risk factors.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying PEN stock.
Penumbra, Inc.'s current P/E is 70.2x. The average P/E over the last 4 quarters is 68.7x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Penumbra, Inc.'s current operating margin is 13.5%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Penumbra, Inc.'s business trajectory between earnings reports.